A Qualitative Study of Clinician Barriers and Facilitators to De-escalation of Thyroid Stimulating Hormone Suppression in Thyroid Cancer Survivors
We identified barriers and facilitators to de-escalating TSH suppression therapy in thyroid cancer survivors at multiple levels. Understanding these factors will enable clinicians to provide high-value, patient-centered care in order to reduce overtreatment, patient harm and improve quality of life in thyroid cancer survivors.
Authors
- Maria Papaleontiou (ORCID: https://orcid.org/0000-0003-2276-0046)
- Megan R. Haymart (ORCID: https://orcid.org/0000-0002-1083-1575)
- Chiu Yi Tan (ORCID: https://orcid.org/0000-0001-6434-7749)
- Nina Francis-Levin
- Brittany Gay
Institutions
- University of Michigan (US)
- Michigan Medicine (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Endocrine Practice
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1016/j.eprac.2025.12.009
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00